scholarly article | Q13442814 |
P2093 | author name string | Stephen Safe | |
Alan McAlees | |||
Gayathri Chadalapaka | |||
Indira Jutooru | |||
Tom Stefanac | |||
P2860 | cites work | A history of the therapeutic use of liquorice in Europe | Q36174968 |
2-cyano-lup-1-en-3-oxo-20-oic acid, a cyano derivative of betulinic acid, activates peroxisome proliferator-activated receptor gamma in colon and pancreatic cancer cells | Q40088710 | ||
Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cells | Q40130462 | ||
Synthetic oleanane and ursane triterpenoids with modified rings A and C: a series of highly active inhibitors of nitric oxide production in mouse macrophages | Q43509294 | ||
Design and synthesis of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, a novel and highly active inhibitor of nitric oxide production in mouse macrophages | Q77749464 | ||
Pharmacology of oleanolic acid and ursolic acid | Q28292594 | ||
Novel synthetic oleanane and ursane triterpenoids with various enone functionalities in ring A as inhibitors of nitric oxide production in mouse macrophages | Q28378280 | ||
A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma | Q31483885 | ||
Betulinic acid and its derivatives: a review on their biological properties | Q36079811 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell growth | Q189159 |
pancreatic cancer | Q212961 | ||
P304 | page(s) | 2633-2639 | |
P577 | publication date | 2008-03-14 | |
P1433 | published in | Bioorganic & Medicinal Chemistry Letters | Q2709483 |
P1476 | title | Structure-dependent inhibition of bladder and pancreatic cancer cell growth by 2-substituted glycyrrhetinic and ursolic acid derivatives | |
P478 | volume | 18 |
Q35923150 | Age-associated chronic diseases require age-old medicine: role of chronic inflammation |
Q39346069 | An Overview of Structurally Modified Glycyrrhetinic Acid Derivatives as Antitumor Agents |
Q38713053 | Bardoxolone Methyl and a Related Triterpenoid Downregulate cMyc Expression in Leukemia Cells. |
Q37854752 | Clinically useful anticancer, antitumor, and antiwrinkle agent, ursolic acid and related derivatives as medicinally important natural product |
Q38125067 | Cytotoxic activity of ursolic acid derivatives obtained by isolation and oxidative derivatization. |
Q35108020 | Evolution in medicinal chemistry of ursolic acid derivatives as anticancer agents |
Q38892406 | Glycyrrhetinic acid potently suppresses breast cancer invasion and metastasis by impairing the p38 MAPK-AP1 signaling axis |
Q55076389 | HDAC and Ku70 axis- an effective target for apoptosis induction by a new 2-cyano-3-oxo-1,9-dien glycyrrhetinic acid analogue. |
Q30318376 | Improvement of the cytotoxicity and tumor selectivity of glycyrrhetinic acid by derivatization with bifunctional amino acids. |
Q37351464 | Induction of apoptosis and nonsteroidal anti-inflammatory drug-activated gene 1 in pancreatic cancer cells by a glycyrrhetinic acid derivative |
Q42237311 | Induction of apoptosis with mitochondrial membrane depolarization by a glycyrrhetinic acid derivative in human leukemia K562 cells |
Q36783835 | Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters |
Q35083801 | Inhibition of pituitary tumor-transforming gene-1 in thyroid cancer cells by drugs that decrease specificity proteins |
Q34051649 | Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a |
Q41820952 | Oleanolic acid derivatives induce apoptosis in human leukemia K562 cell involved in inhibition of both Akt1 translocation and pAkt1 expression |
Q37397551 | Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells |
Q37173329 | Plant-derived triterpenoids and analogues as antitumor and anti-HIV agents |
Q39312759 | Semisynthetic ursolic acid fluorolactone derivatives inhibit growth with induction of p21(waf1) and induce apoptosis with upregulation of NOXA and downregulation of c-FLIP in cancer cells |
Q27309197 | Synergism of ursolic acid derivative US597 with 2-deoxy-D-glucose to preferentially induce tumor cell death by dual-targeting of apoptosis and glycolysis |
Q39590536 | Synthesis and pro-apoptotic activity of novel glycyrrhetinic acid derivatives. |
Q42958718 | The synthesis of glycyrrhetinic acid derivatives containing a nitrogen heterocycle and their antiproliferative effects in human leukemia cells. |
Q36494764 | Unifying mechanisms of action of the anticancer activities of triterpenoids and synthetic analogs |
Q39614477 | Ursolic acid induces apoptosis by suppressing the expression of FoxM1 in MCF-7 human breast cancer cells |
Q36916312 | Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine |
Q37022420 | Ursolic acid inhibits the growth of human pancreatic cancer and enhances the antitumor potential of gemcitabine in an orthotopic mouse model through suppression of the inflammatory microenvironment |
Q34125151 | Use of dietary phytochemicals to target inflammation, fibrosis, proliferation, and angiogenesis in uterine tissues: promising options for prevention and treatment of uterine fibroids? |
Search more.